Cargando…
PSUN53 Using Renin Activity to Guide Mineralocorticoid Receptor Antagonist Therapy in Patients with Low-Renin Hypertension
Emerging studies show that beyond a phenotype of overt primary aldosteronism, there exists a prevalent phenotype of renin-independent aldosterone production among patients with low-renin hypertension (LRH). Mineralocorticoid receptor antagonist (MRA) therapy to induce an increase in renin is associa...
Autores principales: | Mansur, Arian, Vaidya, Anand, Turchin, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624601/ http://dx.doi.org/10.1210/jendso/bvac150.524 |
Ejemplares similares
-
Using Renin Activity to Guide Mineralocorticoid Receptor Antagonist Therapy in Patients with Low Renin and Hypertension
por: Mansur, Arian, et al.
Publicado: (2023) -
The Low-Renin Hypertension Phenotype: Genetics and the Role of the Mineralocorticoid Receptor
por: Baudrand, Rene, et al.
Publicado: (2018) -
PSUN68 Finerenone for Primary Aldosteronism: A Novel Mineralocorticoid Receptor Antagonist
por: Aurora, John, et al.
Publicado: (2022) -
RF32 | PSUN49 To Repeat or Not to Repeat: The Question of Aldosterone and Renin Variability
por: Ng, Elisabeth, et al.
Publicado: (2022) -
PSUN52 Patients with Left Ventricular Hypertrophy on Echocardiography are Frequently Evaluated with Renin and Aldosterone
por: Lieberman, Leedor, et al.
Publicado: (2022)